Bill Text: GA HB194 | 2009-2010 | Regular Session | Comm Sub
Bill Title: Brand name drugs; substitute generic drugs; provisions
Spectrum: Slight Partisan Bill (Republican 4-2)
Status: (Passed) 2010-10-01 - Effective Date [HB194 Detail]
Download: Georgia-2009-HB194-Comm_Sub.html
10 LC
36 1557S
The
Senate Health and Human Services Committee offered the following substitute to
HB 194:
A
BILL TO BE ENTITLED
AN ACT
AN ACT
To
amend Code Section 26-4-81 of the Official Code of Georgia Annotated, relating
to substitution of generic drugs for brand name drugs, so as to provide that
when a substitution is made certain information relative to the substitution
must appear on the prescription label and be affixed to the container or an
auxiliary label; to provide for related matters; to provide an effective date;
to repeal conflicting laws; and for other purposes.
BE
IT ENACTED BY THE GENERAL ASSEMBLY OF GEORGIA:
SECTION
1.
Code
Section 26-4-81 of the Official Code of Georgia Annotated, relating to
substitution of generic drugs for brand name drugs, is amended by revising
subsection (d) as follows:
"(d)(1)
Whenever a substitution is made, the pharmacist shall record on the original
prescription the fact that there has been a substitution and the identity of the
dispensed drug product and its manufacturer. Such prescription shall be made
available for inspection by the board or its representative in accordance with
the rules of the board.
(2)
If a pharmacist substitutes a generic drug product for a brand name prescribed
drug product when dispensing a prescribed medication, the brand name and the
generic name of the drug product, with an explanation of 'generic for (insert
name of brand name prescribed drug product)' or similar language to indicate
substitution has occurred, must appear on the prescription label and be affixed
to the container or an auxiliary label, unless the prescribing practitioner
indicated that the name of the drug may not appear upon the prescription label;
provided, however, that this paragraph shall not apply to medication dispensed
for in-patient hospital services or to medications in specialty packaging for
dosing purposes as defined by the
board."
SECTION
2.
This
Act shall become effective on October 1, 2010.
SECTION
3.
All
laws and parts of laws in conflict with this Act are repealed.